ShareValue scores for LOTUSEYE.NSE: Valuation 47, Quality 30, Growth 31, Health 43.

Lotus Eye Hospital and Institute Limited logo

LOTUSEYE.NSE
NSE

Lotus Eye Hospital and Institute Limited

₹117.24(-0.50%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 16%
Valuation
47
Fair Value
Price vs Value
Quality
30
Weak
Business Strength
Growth
31
Weak
Revenue & Earnings
Health
43
Moderate
Financial Stability
Momentum
67
Bullish
Price Trend

Company Details

About

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026